期刊
CELL
卷 180, 期 2, 页码 359-+出版社
CELL PRESS
DOI: 10.1016/j.cell.2019.12.013
关键词
-
资金
- NIH Director's Early Independence Award [1DP5OD017892]
- Mathers Foundation [MF1706-00164]
- Mallinckrodt Foundation
- Searle Scholars Program
- Beckman Young Investigator Program
- Sloan Fellowship in Chemistry
- NIH [1DP2GM119419, 2U19AI089992, 5U24AI118672, R01AI080621]
- Bill and Melinda Gates Foundation
Toxoplasma gondii chronically infects a quarter of the world's population, and its recrudescence can cause life-threatening disease in immunocompromised individuals and recurrent ocular lesions in the immunocompetent. Acute-stage tachyzoites differentiate into chronic-stage bradyzoites, which form intracellular cysts resistant to immune clearance and existing therapies. The molecular basis of this differentiation is unknown, despite being efficiently triggered by stresses in culture. Through Cas9-mediated screening and single-cell profiling, we identify a Myb-like transcription factor (BFD1) necessary for differentiation in cell culture and in mice. BFD1 accumulates during stress and its synthetic expression is sufficient to drive differentiation. Consistent with its function as a transcription factor, BFD1 binds the promoters of many stage-specific genes and represents a counterpoint to the ApiAP2 factors that dominate our current view of parasite gene regulation. BFD1 provides a genetic switch to study and control Toxoplasma differentiation and will inform prevention and treatment of chronic infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据